Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-006285
Filing Date
2023-02-02
Accepted
2023-02-02 17:30:22
Documents
1
Period of Report
2023-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4110
  Complete submission text file 0001209191-23-006285.txt   5490
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OLEMA PHARMACEUTICALS, INC. 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address
Horn Kinney (Reporting) CIK: 0001831215 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39712 | Film No.: 23582440